Φορτώνει......
Chronic lymphocytic leukemia therapy: new targeted therapies on the way
INTRODUCTION: The critical role of the tissue microenvironment and B cell receptor (BCR) signaling in chronic lymphocytic leukemia (CLL) pathogenesis, and the clinical success of targeted agents that disrupt BCR signaling are currently changing the CLL landscape. Three new drugs were recently approv...
Αποθηκεύτηκε σε:
Τόπος έκδοσης: | Expert Opin Pharmacother |
---|---|
Κύριοι συγγραφείς: | , |
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
2016
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955400/ https://ncbi.nlm.nih.gov/pubmed/26988407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2016.1168401 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|